Notably, in cholangiocarcinoma, USP9X promotes apoptosis by deubiquitinating EGLN3 and regulating the expression of KIF1Bβ, highlighting its crucial role in tumor suppression [47]. This evidence concerns the gene EGLN3 and neoplasm.